These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2438444)

  • 1. Inhibition of rat natural killer cell function by carcinogenic nickel compounds: preventive action of manganese.
    Judde JG; Breillout F; Clemenceau C; Poupon MF; Jasmin C
    J Natl Cancer Inst; 1987 Jun; 78(6):1185-90. PubMed ID: 2438444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of manganese, calcium, magnesium, and zinc on nickel-induced suppression of murine natural killer cell activity.
    Smialowicz RJ; Rogers RR; Riddle MM; Luebke RW; Fogelson LD; Rowe DG
    J Toxicol Environ Health; 1987; 20(1-2):67-80. PubMed ID: 3806706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nickel--magnesium interactions in carcinogenesis: dose effects and involvement of natural killer cells.
    Kasprzak KS; Ward JM; Poirier LA; Reichardt DA; Denn AC; Reynolds CW
    Carcinogenesis; 1987 Jul; 8(7):1005-11. PubMed ID: 3594718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats.
    Barlozzari T; Reynolds CW; Herberman RB
    J Immunol; 1983 Aug; 131(2):1024-7. PubMed ID: 6863925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-methylcholanthrene: transient inhibition of the lytic step of mouse natural killer cells.
    Kalland T; Forsberg JG
    J Natl Cancer Inst; 1983 Aug; 71(2):385-90. PubMed ID: 6576196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of pulmonary metastases induced by decreased lung natural killer cell activity.
    Nolibé D; Poupon MF
    J Natl Cancer Inst; 1986 Jul; 77(1):99-103. PubMed ID: 3014200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of manganese on carcinogenicity and metabolism of nickel subsulfide.
    Sunderman FW; Kasprzak KS; Lau TJ; Minghetti PP; Maenza RM; Becker N; Onkelinx C; Goldblatt PJ
    Cancer Res; 1976 May; 36(5):1790-800. PubMed ID: 1268836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny.
    Flexman JP; Shellam GR
    Clin Exp Immunol; 1984 Jan; 55(1):229-38. PubMed ID: 6198116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the activity of mouse natural killer cells by urethan.
    Gorelik E; Herberman RB
    J Natl Cancer Inst; 1981 Mar; 66(3):543-8. PubMed ID: 6937709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats.
    Shakhar G; Ben-Eliyahu S
    J Immunol; 1998 Apr; 160(7):3251-8. PubMed ID: 9531281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines involved in the augmentation of murine natural killer cell activity by pyrimidinones in vivo.
    Richard KA; Mortensen RF; Tracey DE
    J Biol Response Mod; 1987 Dec; 6(6):647-63. PubMed ID: 2453616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
    Bukowski JF; Biron CA; Welsh RM
    J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
    Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS; Hawkins MJ; Borden EC
    Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenesis bioassays of nickel oxides and nickel-copper oxides by intramuscular administration to Fischer-344 rats.
    Sunderman FW; Hopfer SM; Plowman MC; Knight JA
    Res Commun Chem Pathol Pharmacol; 1990 Oct; 70(1):103-13. PubMed ID: 2263758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
    Brunda MJ; Rosenbaum D
    Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.